510(k) · Cleared
ClearedNovosyn Quick Absorbable Suture
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Aesculap, Inc. · GAM Suture, Absorbable, Synthetic, Polyglycolic Acid
Cleared on Jun 8, 2017 as substantially equivalent to K122734 (Aesculap, Inc., 2012) and 2 other predicates after a 97-day review. Its family tree reaches back 2 generations to 1998.
- Decided
- Jun 8, 2017
- Review
- 97 days
- Class
- Class II
- Product code
- GAM
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K980704 (1998). 5 ancestors in all, the oldest K944110 (1995). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K980704 | Safil Synthetic Absorbable Surgical Suture | Aesculap, Inc. | 1998 | — |
| −1 | K122734 | Aesculap Novosyn Absorbable Suture | Aesculap, Inc. | 2012 | — |
| 0 (this device) | K170661 | Novosyn Quick Absorbable Suture | Aesculap, Inc. | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 2002 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GAM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GAM device
- #1 K252743 STRATAFIX™ Spiral PDS™ Plus Knotless Tissue…score 14.8 · 15 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K122734 | Aesculap Novosyn Absorbable SutureSummary page 4…his submission is to gain marketing clearance for the Novosyn Quick Absorbable Suture. PREDICATE DEVICE • Primary Predicate: Novosyn Absorbable Suture, Aesculap Inc. (K122734) • Vicryl Rapid Suture, Ethicon Inc. (K962480/K944110) DEVICE DESCRIPTION Novosyn Quick is a synthetic absorbable braided surg… | 2012 |
| * | K962480 | Coated Vicryl Rapide (Polyglactin 910) Braided, Synthetic Absorbable Suture, UndyedSummary page 4…r the Novosyn Quick Absorbable Suture. PREDICATE DEVICE • Primary Predicate: Novosyn Absorbable Suture, Aesculap Inc. (K122734) • Vicryl Rapid Suture, Ethicon Inc. (K962480/K944110) DEVICE DESCRIPTION Novosyn Quick is a synthetic absorbable braided surgical suture which is supplied sterile. Novosyn Q… | 1996 |
| * | K944110 | Vicryl Rapide SutureSummary page 4…vosyn Quick Absorbable Suture. PREDICATE DEVICE • Primary Predicate: Novosyn Absorbable Suture, Aesculap Inc. (K122734) • Vicryl Rapid Suture, Ethicon Inc. (K962480/K944110) DEVICE DESCRIPTION Novosyn Quick is a synthetic absorbable braided surgical suture which is supplied sterile. Novosyn Quick is… | 1995 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 19 years and passes through 1 company; a new generation was cleared every 14.6 years on median.
- 3 of the 5 ancestors have a recall of any class.
- 1 other device also cites its predicate K122734.
How does its category compare?
All GAM devicesGAM Suture, Absorbable, Synthetic, Polyglycolic Acid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · GAM
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GAM
29in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GAM
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GAM
8,970in 2025
MAUDE reports naming product code GAM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 7 | 50 | 10 | 274 |
| 2008 | 6 | 174 | 1 | 194 |
| 2009 | 3 | 10 | 6 | 287 |
| 2010 | 1 | — | 3 | 587 |
| 2011 | 2 | — | 6 | 637 |
| 2012 | 5 | 31 | 0 | 868 |
| 2013 | 1 | — | 0 | 898 |
| 2014 | 10 | 121 | 0 | 1,410 |
| 2015 | 5 | 209 | 0 | 935 |
| 2016 | 3 | 169 | 1 | 1,112 |
| 2017 | 8 | 134 | 1 | 1,499 |
| 2018 | 5 | 98 | 0 | 2,229 |
| 2019 | 4 | 90 | 1 | 3,564 |
| 2020 | 3 | 140 | 44 | 3,415 |
| 2021 | 2 | — | 0 | 4,506 |
| 2022 | 2 | — | 4 | 4,814 |
| 2023 | 1 | — | 0 | 5,070 |
| 2024 | 2 | — | 1 | 7,226 |
| 2025 | 3 | 29 | 0 | 8,970 |
| 2026 | 4 | 131 | 2 | — |
What is it indicated for?
Novosyn Quick Absorbable Suture is indicated for use in general soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Novosyn Quick suture is not intended for use in ligation in ophthalmic, cardiovascular or neurological procedures.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K170661 · printed Nov 6, 2026
Cite this page
510(k) Report. “K170661: Novosyn Quick Absorbable Suture.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170661
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026